The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new guidance, and broader political shifts.
 examines the biggest factors to keep an eye on as the year unfolds.
Also in this issue, we explore the World Health Organisation’s (WHO) , which goes beyond ethnic and gender diversity, attempting to account for patients who are pregnant, lactating, or from low-middle income countries. The issue also features an towards conducting radiopharmaceutical trials.
Following the recent JP Morgan Healthcare Conference, this issue also features which reflects on whether announcements made during the conference indicate a rebound for biopharma M&A activity.
 for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
